These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34045187)

  • 41. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 42. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
    Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
    Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
    Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamics of three-dimensional telomere profiles of circulating tumor cells in patients with high-risk prostate cancer who are undergoing androgen deprivation and radiation therapies.
    Wark L; Klonisch T; Awe J; LeClerc C; Dyck B; Quon H; Mai S
    Urol Oncol; 2017 Mar; 35(3):112.e1-112.e11. PubMed ID: 27956006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups.
    Awe JA; Saranchuk J; Drachenberg D; Mai S
    Urol Oncol; 2017 May; 35(5):300-309. PubMed ID: 28202223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
    Chen JF; Ho H; Lichterman J; Lu YT; Zhang Y; Garcia MA; Chen SF; Liang AJ; Hodara E; Zhau HE; Hou S; Ahmed RS; Luthringer DJ; Huang J; Li KC; Chung LW; Ke Z; Tseng HR; Posadas EM
    Cancer; 2015 Sep; 121(18):3240-51. PubMed ID: 25975562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
    Markou A; Lazaridou M; Paraskevopoulos P; Chen S; Świerczewska M; Budna J; Kuske A; Gorges TM; Joosse SA; Kroneis T; Zabel M; Sedlmayr P; Alix-Panabières C; Pantel K; Lianidou ES
    Clin Chem; 2018 Feb; 64(2):297-306. PubMed ID: 29122836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
    Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
    Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
    Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
    Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
    Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
    Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
    [No Abstract]   [Full Text] [Related]  

  • 52. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
    Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
    Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study.
    Zapatero A; Gómez-Caamaño A; Cabeza Rodriguez MÁ; Muinelo-Romay L; Martin de Vidales C; Abalo A; Calvo Crespo P; Leon Mateos L; Olivier C; Vega Piris LV
    Radiat Oncol; 2020 Jun; 15(1):137. PubMed ID: 32487218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.
    Green BJ; Nguyen V; Atenafu E; Weeber P; Duong BTV; Thiagalingam P; Labib M; Mohamadi RM; Hansen AR; Joshua AM; Kelley SO
    Anal Chem; 2019 Aug; 91(15):9348-9355. PubMed ID: 31264404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.
    Miyamoto DT; Lee RJ; Stott SL; Ting DT; Wittner BS; Ulman M; Smas ME; Lord JB; Brannigan BW; Trautwein J; Bander NH; Wu CL; Sequist LV; Smith MR; Ramaswamy S; Toner M; Maheswaran S; Haber DA
    Cancer Discov; 2012 Nov; 2(11):995-1003. PubMed ID: 23093251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating giant macrophages as a potential biomarker of solid tumors.
    Adams DL; Martin SS; Alpaugh RK; Charpentier M; Tsai S; Bergan RC; Ogden IM; Catalona W; Chumsri S; Tang CM; Cristofanilli M
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3514-9. PubMed ID: 24550495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Challenges in the enumeration and phenotyping of CTC.
    Coumans FA; Ligthart ST; Uhr JW; Terstappen LW
    Clin Cancer Res; 2012 Oct; 18(20):5711-8. PubMed ID: 23014524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma.
    Tada H; Takahashi H; Ida S; Mito I; Matsuyama T; Chikamatsu K
    Anticancer Res; 2021 Feb; 41(2):885-893. PubMed ID: 33517294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.